Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain

View source ↗

Summary

A pediatric study of dupilumab for atopic dermatitis in Spain is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Status: ACTIVE_NOT_RECRUITING